Upcoming Meetings
  • April 29, 2019
    ASGCT 2019 Annual Meeting
  • May 05, 2019
    2019 ASM Clinical Virology Symposium
  • June 07, 2019
    ADA Scientific Sessions 2019
  • June 22, 2019
    SNMMI 2019 Annual Meeting
Press Releases & Media Coverage

ESMO Asia 2019 Congress

Drug used to treat breast cancer effective in prostate tumours too

Times of India (November 23, 2019) SINGAPORE—A drug routinely used to treat women suffering from ovarian and breast cancers, has shown promising results when administered to men in whom prostate cancer had spread to other organs too (metastatic cancer).

SfN 2019 Annual Meeting

The Acoustics of the Brain: Random-access 3D Microscopy in Neuroscience

News-Medical (December 17, 2019) CHICAGO—An interview with Máté Marosi, Ph.D., and Zsolt Iván, PharmD., discussing the use of acousto-optic microscopes to study neural networks in the brain, from cell bodies to dendrites, to tiny spines. This interview was conducted at the Society for Neuroscience annual conference in 2019.

Society for Neuroscience at 50 Delves into Mini Brains, Gene Therapy, Prosthetics and All Else Related to Our Three-Pound Wonder

Scientific American (October 28, 2019) CHICAGO—The organization’s anniversary comes at a time when some scientists have been barred from attending its annual meeting because of the U.S. travel ban.

Promise of treating Alzheimer’s with sensory stimulation: ‘Everybody can do it at home’

Technology Networks (December 2, 2019) CHICAGO—At SfN 2019, [Technology Networks] interviewed Li-Huei Tsai, director of the Picower Institute for Learning and Memory in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology, on the topic of her fascinating research, which explores the effects of modulating brain rhythms in Alzheimer's disease. Tsai presented her work in a plenary lecture at the conference ahead of the findings being explored in a clinical trial. You can read our reporting of her research here. In this interview, we take a deeper look at the field of non-invasive stimulation and hear why it has such a substantial therapeutic promise.

DGHO 2019

Inactive receptor makes cancer immunotherapy ineffective

Innovations Report (October 14, 2019) BERLIN—The aim of immunotherapy is to influence the immune system so that it can fight against tumors again on its own. So-called checkpoint inhibitors are active substances that are already being used clinically. However, they only work in a good third of those affected. A team at the Technical University of Munich (TUM) also demonstrated one of the reasons why this is so using human tissue samples: an inactive receptor in the tumor cells prevents the active substances from reactivating the immune system.

ICRS World Congress Vancouver 2019

Smith+Nephew’s NOVOSTITCH™ Meniscal Repair System shows 91.7% success rate in “STITCH” Study at one-year follow-up

Associated Press (October 9, 2019) VANCOUVER—The STITCH Study is the first prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears (HCTs) - one of the most common meniscal tears affecting approximately one-third of patients with this injury.

ESMO Congress 2019

Freezing desmoid tumors transforms them into a gelatinous mass the body can reabsorb. Is this a possible cure?

Medscape (October 22, 2019) BARCELONA—For patients with a rare form of connective tissue tumor whose condition progresses after medical treatment, total necrosis of their tumor could occur if they are treated with cryoablation, say French researchers.

Pembrolizumab Boosts Survival in Metastatic Nonsquamous NSCLC Regardless of KRAS Mutations

Targeted Oncology (December 16, 2019) BARCELONA—According to an exploratory analysis in the phase III KEYNOTE-042 (NCT02220894) trial, pembrolizumab (Keytruda) showed improvements in overall survival (OS), progression-free survival (PFS), and objective response rate (ORR) compared with pemetrexed or paclitaxel chemotherapy in patients with metastatic nonsquamous non–small cell lung cancer (NSCLC) whose tumors are PD-L1–positive, regardless of their KRAS mutational status.

AHA Scientific Sessions 2018

New cholesterol management guidelines call for personalized risk assessments

The Washington Post (November 10, 2018) CHICAGO—Leading heart experts released cholesterol management guidelines Saturday that call on doctors to tailor treatment to more personalized risk assessments of each patient and recommend the use of two new kinds of drugs for those at the greatest danger of disease.

Coronary calcium screening better predicts heart disease risk, research finds

CNN (November 12, 2018)—CHICAGO Last year, President Donald Trump's doctors screened him for heart disease using a test unfamiliar to many Americans. Now, research shows that that test, either alone or combined with other evaluation methods, is better at predicting whether a symptomatic patient required heart surgery than the standard evaluation.

Vitamin D and Fish Oils Are Ineffective for Preventing Cancer and Heart Disease

The New York Times (November 10, 2018) CHICAGO—The largest study to test vitamin D and omega-3 pills in healthy adults found they did little to prevent cardiovascular disease, but hinted at benefits for groups including African-Americans.

SfN 2018 Annual Meeting

A lack of sleep can induce anxiety

Science News (November 4, 2018) SAN DIEGO—A sleepless night can leave the brain spinning with anxiety the next day. In healthy adults, overnight sleep deprivation triggered anxiety the next morning, along with altered brain activity patterns, scientists reported November 4 at the annual meeting of the Society for Neuroscience.

Active Ingredient In Marijuana Reduced Alzheimer's-Like Effects In Mice

NPR (November 7, 2018) SAN DIEGO—A substance that gives pot its kick appears to reduce the brain changes associated with Alzheimer's disease – at least in mice. In mice that had been genetically tweaked to develop symptoms like those of Alzheimer's, animals that received a synthetic form of tetrahydrocannabinol for six weeks performed as well as healthy mice on a memory test, scientists reported Tuesday at the Society for Neuroscience meeting in San Diego.

ESMO 2018 Congress

Immunotherapy extends lives of patients with aggressive breast cancer, study says

USA Today (October 22, 2018)—MUNICH. Immunotherapy, treatment used to help boost the body's immune system, allowed some patients with an aggressive form of breast cancer to live longer, a study finds.

AstraZeneca's Lynparza shown to put brakes on ovarian cancer

Reuters (October 22, 2018)—MUNICH. An AstraZeneca drug that blocks a cancer cell’s ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.

HFSA 2018 Annual Meeting

Strategies Shorten HF Admissions, Reduce Readmissions

MedPage Today (September 19, 2018)—NASHVILLE. Heart failure admissions can be shortened and readmissions reduced with care management, two trials found with a standardized approach to care and with lung impedance-guided care, respectively. Both trials were presented at the Heart Failure Society of America meeting in Nashville, Tennessee.

AACC 2018 Annual Meeting

Big Developments at AACC 2018 - New Alzheimer's Test, Chagas Detection, Faster Microbiology...

PR Newswire (July 30, 2018)—CHICAGO. Currently, the diagnosis of Alzheimer's is largely based on clinical symptoms, including cognitive testing, with a significant number of patients diagnosed when their disease has already advanced. The IVD Industry has sought to change that. Now, Roche Diagnostics has announced that U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.

AOSSM 2018 Annual Meeting

Study: Fatigue fuels ACLS injuries in young athletes

United Press International (July 6, 2018) SAN DIEGO—When a teen is tired, the risk of injury to the anterior cruciate ligament rises, a new study suggests.

AACR Annual Meeting 2018

Lung Cancer Patients Live Longer with Immune Therapy

New York Times (April 16, 2018) CHICAGO—Odds of survival can greatly improve for people with the most common type of lung cancer if they are given a new drug that activates the immune system along with chemotherapy, a major new study has shown.

Children with non-chromosomal birth defects face higher risk of several childhood cancers

Medical Xpress (April 16, 2018) CHICAGO—Children with non-chromosomal birth defects such as congenital heart disease had a significantly higher risk of developing childhood cancer than children who did not have birth defects, according to a study presented at the AACR Annual Meeting 2018.

Endocrine Society Annual Meeting 2018

Diabetes medicine reduces liver fat in nonalcoholic fatty liver disease

Endocrine Society (March 18, 2018) CHICAGO—A study has found that empagliflozin, a newer treatment for type 2 diabetes, reduces liver fat in patients with NAFLD and diabetes.

Chemicals in Lavender and Tea Tree Oil Appear to Be Hormone Disruptors

Endocrine News (March 18, 2018) CHICAGO—A new study lends further evidence to a suspected link between prepubertal gynecomastia and regular exposure to lavender or tea tree oil, by finding that key chemicals in these common plant-derived oils act as endocrine-disrupting chemicals.

Promising Male Birth Control Pill Is Safe and Effective, Study Says

TIME (March 19, 2018) CHICAGO—The female birth control pill has stood on the market alone for decades. Now, a male birth control pill could be inching closer to reality, according to the results of a small new study presented in Chicago at the annual Endocrine Society meeting.

Artificial pancreas safe, effective in young children with type 1 diabetes

Healio (March 19, 2018) CHICAGO—According to study data presented at the Endocrine Society Annual Meeting, children aged 7 to 13 years with type 1 diabetes who used an artificial pancreas system for 3 months experienced a reduction in HbA1c and an improvement in time to glucose values in the target range, without any episodes of severe hypoglycemia or diabetic ketoacidosis.

New Data Presented at the Endocrine Society's 2018 Annual Meeting Advances Understanding of the Rare Disease Chronic Hypoparathyroidism

Global Newswire (March 20, 2018) Shire PLC announced new data on its recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) in patients with chronic hypoparathyroidism.

European Congress of Radiology 2018

Canon Medical Systems Corporation Participating at the European Congress of Radiology (ECR) 2018

Samsung Newsroom (March 1, 2018) Samsung Electronics is displaying medical equipment based on its  ‘AccE™’ (Access, Accuracy and Efficiency) strategy, which aims to change the industry by incorporating innovations in physical access to provide care wherever needed.

National Decision Support Company and European Society of Radiology launch ESR iGuide web portal

About Pharma Online (March 1, 2018) NDSC Europe and the European Society of Radiology have launched a web portal that will provide access to referral guidelines for medical imaging to individual members, healthcare providers, medical societies, and other organizations.  

SMFM Annual Pregnancy Meeting 2018

Low Cost, Easy to Administer Drug May be the Key to Preventing Maternal Deaths

Society for Maternal-Fetal Medicine (January 29, 2018) DALLAS—According to a study presented at the Annual Pregnancy Meeting, tranexamic acid prevents blood loos after births and postpartum hemorrhage after operative delivery. 

Researchers Advance the Understanding of Preterm Birth

Society for Maternal-Fetal Medicine (January 30, 2018) DALLAS—A study presented at the annual meeting showed that the byproducts of bacteria induce cervical changes which may lead to preterm birth. 

Prompt clot-grabbing treatment produces better stroke outcomes

American Heart Association (January 25, 2018) LOS ANGELES—According to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, clot removal may be beneficial up to 24 hours following stroke in carefully selected patients. 

ASA Practice Management 2018

Surgery Patients in Enhanced Recovery Program Leave Hospital Sooner

American Society of Anesthesiologists (January 26, 2018) NEW ORLEANS—According to new research presented at the American Society of Anesthesiologists Practice Management 2018 meeting, colorectal and bariatric surgery patients benefited from an enhanced recovery after surgery (ERAS) program. 

AHA/ASA International Stroke Conference 2018

Genetic ancestry test beats self-reports in predicting bleeding stroke risk

American Heart Association (January 24, 2018) LOS ANGELES—According to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a genetic ancestry test more accurately identified patients at risk for bleeding stroke than traditional self-reports of race, cultural identity, or ethnicity. 

SfN Annual Conference 2017

Military Service Members Face Unique and Sustained Threats to Optimal Brain Health

Society for Neuroscience (November 12, 2017) WASHINGTON DC—New research examines the effects of military-related brain disorders and possible paths toward treatment, as well as a potential way to harness our brain’s learning capabilities to better train pilots.

Research Advances Understanding of Opioid Addiction in Face of Public Health Crisis

Society for Neuroscience (November 13, 2017) WASHINGTON DC—As the United States grapples with the devastating effects of an opioid epidemic, researchers are making progress in advancing our understanding of opioid addiction–related health issues, according to studies presented at Neuroscience 2017.

Sex Matters in Experiments on Party Drug—in Mice

Scientific American (November 20, 2017) WASHINGTON DC—A study presented at the Society for Neuroscience (SfN) meeting suggests that mouse experiments with the popular club drug ketamine may be skewed by the sex of the researcher performing them.

Studies Uncover the Hard-Hitting Consequences of Sports-Related Head Injuries

Society for Neuroscience (November 14, 2017) WASHINGTON DC—Playing contact sports can injure the brain even if head impacts don’t result in concussions, according to new research presented today at Neuroscience 2017

AHA Scientific Conferences 2017

Sixth-graders can learn, perform Hands-Only CPR

American Heart Association (November 11, 2017) ANAHEIM—Students as young as sixth-graders can learn and perform CPR effectively and should be targeted for training, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017.

Heart failure in methamphetamine users: could this be the next epidemic among vets?

American Heart Association (November 14, 2017) ANAHEIM—Heart failure associated with methamphetamine (meth) use has risen dramatically in recent years among U.S. veterans, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017.

ACEP Annual Conference 2017

Naloxone reverses 93% of overdoses, but many recipients don’t survive a year

CNN (October 30, 2017) WASHINGTON DC—A review of emergency medical services data from Massachusetts found that when given naloxone, 93.5% of people survived their overdose. The findings are being presented Monday at the American College of Emergency Physicians' annual conference in Washington.

AACR-NCI-EORTC International Conference 2017

Number of Seamless Clinical Trials in Oncology Has Risen Recently

American Association of Cancer Research (October 27, 2017) PHILADELPHIA—The number of early-phase trials in oncology that adopted a seamless approach, as opposed to a traditional trial approach, is rising according to a study presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. 

NCI-MATCH Reaches Central Patient screening Goal

American Association of Cancer Research (October 27, 2017) PHILADELPHIA—The National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) clinical trial has achieved the goal of screening nearly 6,000 patients in just under two years, according to data presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

ASA Annual Meeting 2017

Women who give birth in winter or spring are less likely to have postpartum depression

American Society of Anesthesiologists (October 22, 2017) BOSTON—The study included a review of medical records of 20,169 women who delivered babies from June 2015 through August 2017. 

What’s snow got to do with it? Most elderly hip fractures occur in warm months and indoors

American Society of Anesthesiologists (October 23, 2017) BOSTON—A preliminary study presented at the Anesthesiology 2017 Annual Meeting shows that the majority of falls occur during warm months, and a greater number of the falls happen indoors rather than out.

Eliminating opioids from anesthesia decreases post-surgery nausea, study shows

American Society of Anesthesiologists (October 23, 2017) BOSTON—Opioid-free general anesthesia is safe, effective and dramatically decreases postoperative nausea, according to a single-center study of more than 1,000 patients being presented at the Anesthesiology 2017 Annual Meeting.

AFP Annual Conference 2017

World Vision International Wins 2017 AFP Pinnacle Award Grand Prize for Excellence in Treasury and Finance

Association for Financial Professionals (October 16, 2017) SAN DIEGO—World Vision International was awarded the Association for Financial Professionals 2017 Pinnacle Grand Prize at the Opening General Session of AFP 2017 in San Diego.

IAS Conference on HIV Science 2017

IAS and WHO identify the most critical research needs for infants, children and adolescents living with HIV

World Health Organization (July 23, 2017) PARIS—The most pressing gaps in research needed to improve outcomes for children and adolescents living with HIV are highlighted in the first global priority research agendas on pediatric and adolescent HIV, released at the 9th IAS Conference on HIV Science.

Child Living with HIV maintains remission without drugs since 2008

National Institutes of Health (July 24, 2017) PARIS—Scientists reported that a nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years.

AOSSM Annual Meeting 2017

Assessing Concussion Symptom Presentation May Provide Insight into Rise in Rates

American Orthopaedic Society For Sports Medicine (July 21, 2017) TORONTO—How physicians and athletic trainers assess symptoms may give insight into why concussion rates are on the rise, say researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s Annual Meeting.

Success at the High School, Collegiate and Professional Levels Not Necessarily Related to Early Sports Specialization

American Orthopaedic Society For Sports Medicine (July 23, 2017) TORONTO—Specializing in one sport early in a child’s athletic career is often touted as a way to gain that elusive college scholarship or even go on to the pros. However, researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Canada today say “not so fast.” 

Outreach Athletic Trainers Have a Positive Economic Impact on Sports Coverage for Health Systems and Patients

American Orthopaedic Society For Sports Medicine (July 21, 2017) TORONTO—The cost-effectiveness of certified outreach athletic trainers (ATC) as a type of physician extender in an orthopaedic provider and/or hospital system setting has many benefits, both financially and with patient care say researchers.

ADA Scientific Sessions 2017

A Two-Way Text Messaging System Benefits Glycemic Control for Teens with Type 1 Diabetes

American Diabetes Association (June 10, 2017) SAN DIEGO—Teens with type 1 diabetes (T1D) who adhere to frequent communication through a two-way text messaging system were found to maintain or improve A1C levels while preparing to transition from pediatric to adult care settings

New, Long-Acting Insulin Therapy Demonstrates Cardiovascular Safety and Reduces the Risk of Severe Hypoglycemia

American Diabetes Association (June 12, 2017) SAN DIEGO—A new, ultra-long acting insulin product, insulin degludec, has comparable cardiovascular safety to insulin glargine U100 and is also associated with significant reductions in severe hypoglycemia.

Long-Term Metformin Treatment Found to Reduce Risk of Heart Disease in Adults with Type 1 Diabetes

American Diabetes Association (June 11, 2017) SAN DIEGO—Metformin may be an effective long-term strategy worthy of adding to an individual’s diabetes care plan in order to reduce the risk of heart disease in adults with type 1 diabetes.

San Antonio Breast Cancer Symposium 2017

Myriad’s riskScore test for breast cancer risk adds a second layer of precision

MedCity News (December 6, 2017) SAN ANTONIO—On day two of the 2017 San Antonio Breast Cancer Symposium, Myriad Genetics unveiled pivotal validation data in support of its new riskScore genetic test designed to quantify a woman’s five-year and lifetime risk of developing breast cancer.

Dose-Dense Chemotherapy Improves Outcomes in Breast Cancer

Medscape (December 6, 2017) SAN ANTONIO—A study presented at the San Antonio Breast Cancer Symposium shows that shortening the interval between chemotherapy cycles or administrating anthracycline and a taxane sequentially instead of giving them together, significantly lowers the risk for breast cancer recurrence and death from breast cancer.